Esophoria at near is a risk factor for myopia development and progression. Does it need to be managed in an emmetropic patient without symptoms? Is this patient a pre-myope, and how should this factor into management? Read this interesting clinical case, where colleagues discuss whether to intervene or not, and how to potentially manage both myopia risk and binocular vision.
Here we explore an overview of spectacle prescribing for myopia management – from when to use single vision, to progressive and bifocal designs, new myopia control specific designs, and whether to fully or under-correct.
Given their lower efficacy compared to contact lens options, is the additional cost of a progressive or bifocal spectacle lens worth it for myopia control? This discussion in the Myopia Profile Facebook group explores the options, with links to further reading.
Podcast summary: Lyndon and Debbie Jones from the Centre for Ocular Research and Education and University of Waterloo, Canada, highlight
There’s a little more to think about in the important role spectacle lenses play in myopia management. Even if we prescribe contact lenses, our young myopes are most likely to need a back up spectacle lens option. Children prescribed atropine will need the best spectacle lens prescribed for them to minimise the impact of any side effects.
Are progressive addition lenses and bifocals created equal for myopia control? When do they work and when do spectacles have minimal efficacy? How should we pick which lens type to prescribe, and what’s on the horizon for our non-contact lens wearing young myopes?
